AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
Auryon Platform Revenue: $16.3 million, growing 17.9% year-over-year. Mechanical Thrombectomy Revenue: $11.5 million, a 17.9% increase year-over-year. AlphaVac Revenue: $4.4 million, a 47.4% year-over-year increase. AngioVac Revenue: $7.2 million, a 5% year-over-year increase. NanoKnife Revenue: $7.6 million, an increase of 21%. Gross Margin: 52.9%, a 110 basis point decrease from the previous year. Operating Expenses: $54.4 million, representing 69% of sales. Adjusted Net Loss: $3 million or an adjusted loss per share of $0.07. Adjusted EBITDA: $1.8 million, compared to $1.3 million in the previous year. Cash Position: $37.8 million as of February 28, 2026. Full Year Revenue Guidance: Raised to $313.5 million to $315.5 million. Med Tech Sales Growth Guidance: Raised to 15% to 17%. Adjusted EBITDA Guidance: Raised to $10 million to $12 million. Adjusted Loss Per Share Guidance: Improved to a range of $0.30 to $0.23. Warning! GuruFocus has detected 4 Warnin
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- AngioDynamics (ANGO) had its price target lowered by Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- AngioDynamics Growing, But With More Noise Than The Street Likes [Seeking Alpha]Seeking Alpha
- AngioDynamics Q3 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued ProfitabilityBusiness Wire
- AngioDynamics (ANGO) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
ANGO
Earnings
- 4/2/26 - Beat
ANGO
Analyst Actions
- 4/6/26 - Canaccord Genuity
ANGO
Sec Filings
- 4/2/26 - Form 10-Q
- 4/2/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- ANGO's page on the SEC website